H1B Report
Side-by-side comparison

COGNIZANT TECHNOLOGY SOLUTIONS US CORP vs Parkview Health System, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155
Entity B
Parkview Health System, Inc.
INRank #FEIN 35-1972384

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCOGNIZANT TECHNOLOGY SOLUTIONS US CORPParkview Health System, Inc.
Total filings128,85261
Certified %96.13%98.36%
Denied %0.28%0.00%
Withdrawn %2.23%1.64%
Cert-withdrawn %1.36%0.00%
Rank#2
Active yearsFY2010–FY2026FY2012–FY2026
Worksite stateTXIN

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Outcomes — Parkview Health System, Inc.

DOL case-status mix.

Outcome breakdown: Certified 98.4%, Withdrawn 1.6%
Outcome breakdown
OutcomeShare
Certified98.4%
Withdrawn1.6%
Certified98.4%
Withdrawn1.6%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779
Parkview Health System, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20121
FY20131
FY20140
FY20151
FY20162
FY20171
FY20184
FY20192
FY20202
FY20210
FY20222
FY20233
FY202412
FY202514
FY202616

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Top 5 occupations — Parkview Health System, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.